This report was recently updated on November 16 2024 with the latest and most recent
market numbers
Global Regenerative Medicine Market Size, Trends & Analysis - Forecasts to 2029 By Product (Therapeutics, Tools, Banks, and Services), By Therapeutic (Dermatology, Musculoskeletal, Immunology & Inflammation, Oncology, Cardiovascular, Ophthalmology, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global regenerative medicine market is projected to grow at a CAGR of 17.09% from 2024 to 2029.
Innovations in stem cell research, tissue engineering, nanomaterials, and gene therapy have transformed regenerative medicine. Stem cell research offers varied tools for tissue regeneration, whereas tissue engineering techniques produce functioning biological alternatives. Biomaterials provide scaffolding for tissue growth, whereas gene therapy enables focused interventions. Together, these developments broaden the scope of regenerative medicine, contributing to its evolution and commercialization.
The global increase in chronic diseases such as cancer, cardiovascular, neurological, and orthopedic disorders creates a need for novel treatments. Regenerative medicine stands out as a possible answer, providing therapies that can regenerate or replace damaged tissues and organs. By treating the underlying causes of these illnesses, regenerative medicine has the potential to have a transformative impact, fulfilling the world's expanding healthcare requirements.
As the world's population ages, the prevalence of age-related diseases and disorders rises. Regenerative medicine shows significant potential for treating age-related degenerative disorders by restoring tissue and organ function, driving market growth. According to the World Health Organization, by 2030, approximately one-sixth of the global population will be 60 or older, representing a significant increase from 1 billion in 2020 to 1.4 billion in 2030. By 2050, the elderly population aged 60 and above is projected to double to 2.1 billion. Additionally, the number of individuals aged 80 and above is anticipated to triple by 2050, reaching 426 million, compared to the figures recorded in 2020.
However, the regulatory environment for regenerative medicine is complex. Stringent regulatory standards and licensing processes cause innovative therapies to be delayed in the market and cost more to develop.
The therapeutics segment is expected to hold the largest share of the market. The segment's growth is due to the rising demand for novel treatments for chronic diseases and age-related ailments. Therapeutic products provide solutions for tissue repair, organ regeneration, and illness management, contributing to their largest market share. Furthermore, advances in stem cell research, gene therapy, and tissue engineering have resulted in the creation of successful therapeutic approaches, contributing to the segment's dominance.
The banks segment is expected to be the fastest-growing segment in the market from 2024 to 2029. Growing investment in stem cell banking and increased awareness of stem cells' potential for therapeutic uses are boosting demand for banking services. Furthermore, the increased use of stem cells in research, drug development, and customized medicine is contributing to the rapid growth of this segment.
The cardiovascular segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. The rising global frequency of cardiovascular illnesses, along with restricted treatment choices, fuels the need for novel therapeutics. Regenerative medicine, which includes stem cell therapy and tissue engineering, provides potential methods for repairing damaged cardiac tissue and restoring heart function.
The oncology segment is expected to hold the largest share of the market. The segment's growth is attributed to the increasing global prevalence of cancer and the need for effective treatments. Immunotherapy, targeted cell-based therapies, and tissue engineering are examples of regenerative therapies that offer promising cancer treatment options. According to the World Health Organization (WHO), the global incidence of cancer is on the rise, with a projected 77% increase to approximately 35 million new cases by 2050 compared to 2022.
North America is expected to hold the largest share of the global market. The primary reasons boosting the market growth in this region include advanced healthcare infrastructure, significant R&D investments, and legislative frameworks that encourage innovation. Furthermore, the increased prevalence of chronic diseases and the growing use of regenerative therapies add to the region's dominance in the market.
Asia Pacific is predicted to witness rapid growth during the forecast period. The region's large population base, rising healthcare costs, and increasing frequency of chronic diseases are all factors driving this expansion. Furthermore, supportive government initiatives, growing biotechnology and pharmaceutical sectors, and increased investments in healthcare infrastructure all contribute to the region's rapid growth of the regenerative medicine market.
AstraZeneca plc, F. Hoffmann-La Roche Ltd., Integra Lifesciences Corp., Astellas Pharma, Inc., Cook Biotech, Inc., Bayer AG, Pfizer, Inc., Merck KGaA, Abbott, and Vericel Corp., among others, are some of the key players operating in the global regenerative medicine market.
Please note: This is not an exhaustive list of companies profiled in the report.
In November 2023, AstraZeneca announced a significant licensing agreement with Eccogene for the development and commercialization of ECC5004, an oral glucagon-like peptide 1 receptor agonist (GLP-1RA). This novel agent shows promise in treating cardiometabolic conditions such as obesity and type-2 diabetes. The agreement grants AstraZeneca exclusive global rights for the development and commercialization of ECC5004, except in China, where Eccogene retains the right to co-develop and co-commercialize alongside AstraZeneca.
In February 2024, RTI Surgical, a leading contract development and manufacturing organization (CDMO) in the regenerative medicine industry, finalized its acquisition of Cook Biotech Incorporated. This acquisition enhances RTI's capabilities in regenerative medicine and expands its portfolio of allograft and xenograft biomaterial.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL REGENERATIVE MEDICINE MARKET, BY THERAPEUTIC
4.1 Introduction
4.2 Regenerative Medicine Market: Therapeutic Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Dermatology
4.4.1 Dermatology Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Musculoskeletal
4.5.1 Musculoskeletal Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Immunology & Inflammation
4.6.1 Immunology & Inflammation Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Oncology
4.7.1 Oncology Market Estimates and Forecast, 2021-2029 (USD Million)
4.8 Cardiovascular
4.8.1 Cardiovascular Market Estimates and Forecast, 2021-2029 (USD Million)
4.9 Ophthalmology
4.9.1 Ophthalmology Market Estimates and Forecast, 2021-2029 (USD Million)
4.10 Others
4.10.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT
5.1 Introduction
5.2 Regenerative Medicine Market: Product Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Therapeutics
5.4.1 Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Tools
5.5.1 Tools Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Banks
5.6.1 Banks Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Services
5.7.1 Services Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION
6.1 Introduction
6.2 North America Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Therapeutic
6.2.2 By Product
6.2.3 By Country
6.2.3.1 U.S. Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Therapeutic
6.2.3.1.2 By Product
6.2.3.2 Canada Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Therapeutic
6.2.3.2.2 By Product
6.2.3.3 Mexico Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Therapeutic
6.2.3.3.2 By Product
6.3 Europe Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Therapeutic
6.3.2 By Product
6.3.3 By Country
6.3.3.1 Germany Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Therapeutic
6.3.3.1.2 By Product
6.3.3.2 U.K. Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Therapeutic
6.3.3.2.2 By Product
6.3.3.3 France Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Therapeutic
6.3.3.3.2 By Product
6.3.3.4 Italy Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Therapeutic
6.3.3.4.2 By Product
6.3.3.5 Spain Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Therapeutic
6.3.3.5.2 By Product
6.3.3.6 Netherlands Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Therapeutic
6.3.3.6.2 By Product
6.3.3.7 Rest of Europe Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Therapeutic
6.3.3.6.2 By Product
6.4 Asia Pacific Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Therapeutic
6.4.2 By Product
6.4.3 By Country
6.4.3.1 China Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Therapeutic
6.4.3.1.2 By Product
6.4.3.2 Japan Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Therapeutic
6.4.3.2.2 By Product
6.4.3.3 India Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Therapeutic
6.4.3.3.2 By Product
6.4.3.4 South Korea Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Therapeutic
6.4.3.4.2 By Product
6.4.3.5 Singapore Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Therapeutic
6.4.3.5.2 By Product
6.4.3.6 Malaysia Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Therapeutic
6.4.3.6.2 By Product
6.4.3.7 Thailand Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Therapeutic
6.4.3.6.2 By Product
6.4.3.8 Indonesia Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Therapeutic
6.4.3.7.2 By Product
6.4.3.9 Vietnam Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Therapeutic
6.4.3.8.2 By Product
6.4.3.10 Taiwan Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Therapeutic
6.4.3.10.2 By Product
6.4.3.11 Rest of Asia Pacific Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Therapeutic
6.4.3.11.2 By Product
6.5 Middle East and Africa Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Therapeutic
6.5.2 By Product
6.5.3 By Country
6.5.3.1 Saudi Arabia Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Therapeutic
6.5.3.1.2 By Product
6.5.3.2 U.A.E. Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Therapeutic
6.5.3.2.2 By Product
6.5.3.3 Israel Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Therapeutic
6.5.3.3.2 By Product
6.5.3.4 South Africa Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Therapeutic
6.5.3.4.2 By Product
6.5.3.5 Rest of Middle East and Africa Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Therapeutic
6.5.3.5.2 By Product
6.6 Central and South America Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Therapeutic
6.6.2 By Product
6.6.3 By Country
6.6.3.1 Brazil Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Therapeutic
6.6.3.1.2 By Product
6.6.3.2 Argentina Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Therapeutic
6.6.3.2.2 By Product
6.6.3.3 Chile Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Therapeutic
6.6.3.3.2 By Product
6.6.3.3 Rest of Central and South America Regenerative Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Therapeutic
6.6.3.3.2 By Product
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 AstraZeneca plc
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 F. Hoffmann-La Roche Ltd.
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Integra Lifesciences Corp.
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Astellas Pharma, Inc.
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Cook Biotech, Inc.
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 Bayer AG
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Pfizer, Inc.
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Merck KGaA
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Abbott
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Vericel Corp.
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
2 Dermatology Market, By Region, 2021-2029 (USD Mllion)
3 Musculoskeletal Market, By Region, 2021-2029 (USD Mllion)
4 Oncology Market, By Region, 2021-2029 (USD Mllion)
5 Cardiovascular Market, By Region, 2021-2029 (USD Mllion)
6 Immunology & Inflammation Market, By Region, 2021-2029 (USD Mllion)
7 Ophthalmology Market, By Region, 2021-2029 (USD Mllion)
8 Others Market, By Region, 2021-2029 (USD Mllion)
9 Global Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
10 Therapeutics Market, By Region, 2021-2029 (USD Mllion)
11 Tools Market, By Region, 2021-2029 (USD Mllion)
12 Banks Market, By Region, 2021-2029 (USD Mllion)
13 Services Market, By Region, 2021-2029 (USD Mllion)
14 Regional Analysis, 2021-2029 (USD Mllion)
15 North America Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
16 North America Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
17 North America Regenerative Medicine Market, By COUNTRY, 2021-2029 (USD Mllion)
18 U.S. Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
19 U.S. Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
20 Canada Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
21 Canada Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
22 Mexico Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
23 Mexico Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
24 Europe Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
25 Europe Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
26 Europe Regenerative Medicine Market, By Country, 2021-2029 (USD Mllion)
27 Germany Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
28 Germany Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
29 U.K. Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
30 U.K. Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
31 France Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
32 France Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
33 Italy Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
34 Italy Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
35 Spain Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
36 Spain Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
37 Netherlands Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
38 Netherlands Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
39 Rest Of Europe Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
40 Rest Of Europe Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
41 Asia Pacific Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
42 Asia Pacific Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
43 Asia Pacific Regenerative Medicine Market, By Country, 2021-2029 (USD Mllion)
44 China Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
45 China Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
46 Japan Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
47 Japan Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
48 India Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
49 India Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
50 South Korea Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
51 South Korea Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
52 Singapore Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
53 Singapore Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
54 Thailand Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
55 Thailand Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
56 Malaysia Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
57 Malaysia Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
58 Indonesia Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
59 Indonesia Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
60 Vietnam Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
61 Vietnam Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
62 Taiwan Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
63 Taiwan Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
64 Rest of APAC Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
65 Rest of APAC Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
66 Middle East and Africa Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
67 Middle East and Africa Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
68 Middle East and Africa Regenerative Medicine Market, By Country, 2021-2029 (USD Mllion)
69 Saudi Arabia Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
70 Saudi Arabia Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
71 UAE Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
72 UAE Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
73 Israel Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
74 Israel Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
75 South Africa Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
76 South Africa Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
77 Rest Of Middle East and Africa Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
78 Rest Of Middle East and Africa Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
79 Central and South America Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
80 Central and South America Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
81 Central and South America Regenerative Medicine Market, By Country, 2021-2029 (USD Mllion)
82 Brazil Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
83 Brazil Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
84 Chile Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
85 Chile Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
86 Argentina Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
87 Argentina Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
88 Rest Of Central and South America Regenerative Medicine Market, By Therapeutic, 2021-2029 (USD Mllion)
89 Rest Of Central and South America Regenerative Medicine Market, By Product, 2021-2029 (USD Mllion)
90 AstraZeneca plc: Products & Services Offering
91 F. Hoffmann-La Roche Ltd.: Products & Services Offering
92 Integra Lifesciences Corp.: Products & Services Offering
93 Astellas Pharma, Inc.: Products & Services Offering
94 Cook Biotech, Inc.: Products & Services Offering
95 BAYER AG: Products & Services Offering
96 Pfizer, Inc. : Products & Services Offering
97 Merck KGaA: Products & Services Offering
98 Abbott, Inc: Products & Services Offering
99 Vericel Corp.: Products & Services Offering
100 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Regenerative Medicine Market Overview
2 Global Regenerative Medicine Market Value From 2021-2029 (USD Mllion)
3 Global Regenerative Medicine Market Share, By Therapeutic (2023)
4 Global Regenerative Medicine Market Share, By Product (2023)
5 Global Regenerative Medicine Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Regenerative Medicine Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Regenerative Medicine Market
10 Impact Of Challenges On The Global Regenerative Medicine Market
11 Porter’s Five Forces Analysis
12 Global Regenerative Medicine Market: By Therapeutic Scope Key Takeaways
13 Global Regenerative Medicine Market, By Therapeutic Segment: Revenue Growth Analysis
14 Dermatology Market, By Region, 2021-2029 (USD Mllion)
15 Musculoskeletal Market, By Region, 2021-2029 (USD Mllion)
16 OncologyMarket, By Region, 2021-2029 (USD Mllion)
17 Cardiovascular Market, By Region, 2021-2029 (USD Mllion)
18 Immunology & Inflammation Market, By Region, 2021-2029 (USD Mllion)
19 Ophthalmology Market, By Region, 2021-2029 (USD Mllion)
20 Others Market, By Region, 2021-2029 (USD Mllion)
21 Global Regenerative Medicine Market: By Product Scope Key Takeaways
22 Global Regenerative Medicine Market, By Product Segment: Revenue Growth Analysis
23 Therapeutics Market, By Region, 2021-2029 (USD Mllion)
24 Tools Market, By Region, 2021-2029 (USD Mllion)
25 Banks Market, By Region, 2021-2029 (USD Mllion)
26 Services Market, By Region, 2021-2029 (USD Mllion)
27 Regional Segment: Revenue Growth Analysis
28 Global Regenerative Medicine Market: Regional Analysis
29 North America Regenerative Medicine Market Overview
30 North America Regenerative Medicine Market, By Therapeutic
31 North America Regenerative Medicine Market, By Product
32 North America Regenerative Medicine Market, By Country
33 U.S. Regenerative Medicine Market, By Therapeutic
34 U.S. Regenerative Medicine Market, By Product
35 Canada Regenerative Medicine Market, By Therapeutic
36 Canada Regenerative Medicine Market, By Product
37 Mexico Regenerative Medicine Market, By Therapeutic
38 Mexico Regenerative Medicine Market, By Product
39 Four Quadrant Positioning Matrix
40 Company Market Share Analysis
41 AstraZeneca plc: Company Snapshot
42 AstraZeneca plc: SWOT Analysis
43 AstraZeneca plc: Geographic Presence
44 F. Hoffmann-La Roche Ltd.: Company Snapshot
45 F. Hoffmann-La Roche Ltd.: SWOT Analysis
46 F. Hoffmann-La Roche Ltd.: Geographic Presence
47 Integra Lifesciences Corp.: Company Snapshot
48 Integra Lifesciences Corp.: SWOT Analysis
49 Integra Lifesciences Corp.: Geographic Presence
50 Astellas Pharma, Inc.: Company Snapshot
51 Astellas Pharma, Inc.: Swot Analysis
52 Astellas Pharma, Inc.: Geographic Presence
53 Cook Biotech, Inc.: Company Snapshot
54 Cook Biotech, Inc.: SWOT Analysis
55 Cook Biotech, Inc.: Geographic Presence
56 Bayer AG: Company Snapshot
57 Bayer AG: SWOT Analysis
58 Bayer AG: Geographic Presence
59 Pfizer, Inc. : Company Snapshot
60 Pfizer, Inc. : SWOT Analysis
61 Pfizer, Inc. : Geographic Presence
62 Merck KGaA: Company Snapshot
63 Merck KGaA: SWOT Analysis
64 Merck KGaA: Geographic Presence
65 Abbott, Inc.: Company Snapshot
66 Abbott, Inc.: SWOT Analysis
67 Abbott, Inc.: Geographic Presence
68 Vericel Corp.: Company Snapshot
69 Vericel Corp.: SWOT Analysis
70 Vericel Corp.: Geographic Presence
71 Other Companies: Company Snapshot
72 Other Companies: SWOT Analysis
73 Other Companies: Geographic Presence
The Global Regenerative Medicine Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Regenerative Medicine Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
